PRESS RELEASE published on 04/17/2023 at 08:00, 2 years 11 months ago Defence Therapeutics Inc.: DEFENCE'S NOVEL ACCUMTM-mRNA VACCINE NOW ADMINISTERED FOR TESTING ON CANCER
PRESS RELEASE published on 04/11/2023 at 08:00, 3 years ago DEFENCE BREAKTHROUGH: SUCCESSFULLY ENGINEERED ACCUM(TM) -mRNA VACCINE CREATING A NEW VACCINE PLATFORM. THE IN VIVO ACCUM(TM)-mRNA CANCER VACCINE PROGRAM BEGINS
PRESS RELEASE published on 03/28/2023 at 08:00, 3 years ago DEFENCE TO COMPLETE A FINAL PRE-CLINICAL STUDY PRIOR TO IND FILINGS FOR THE ACCUTOXTM PHASE I CANCER TRIAL AT THE CITY OF HOPE NATIONAL MEDICAL CENTER AND BECKMAN RESEARCH INSTITUTE
PRESS RELEASE published on 03/14/2023 at 08:00, 3 years 1 month ago DEFENCE THERAPEUTICS SIGNS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER
PRESS RELEASE published on 02/27/2023 at 08:00, 3 years 1 month ago DEFENCE’S PIPELINE ADVANCES TO MULTIPLE PHASE I CLINICAL TRIALS
PRESS RELEASE published on 02/21/2023 at 08:00, 3 years 1 month ago Defence Therapeutics Inc.: DEFENCE DELEGATES CITY OF HOPE TO INITIATE IND FILLING FOR ITS ACCUTOXTM CANCER PROGRAM
PRESS RELEASE published on 02/06/2023 at 08:00, 3 years 2 months ago DEFENCE MANUFACTURING ITS ARM VACCINE IN PREPARATION FOR PHASE I CLINICAL TRIAL AGAINST SOLID TUMORS
PRESS RELEASE published on 02/03/2023 at 08:00, 3 years 2 months ago DEFENCE THERAPEUTICS AND CQDM FUND THE DEVELOPMENT OF A NEW CANCER VACCINE PLATFORM
PRESS RELEASE published on 01/31/2023 at 08:00, 3 years 2 months ago Defence Therapeutics Inc.: DEFENCE’S LUNG CANCER GLP TOX STUDY ON ITS INTRANASAL ACCUTOXTM FORMULATION ADVANCES
PRESS RELEASE published on 01/24/2023 at 08:00, 3 years 2 months ago DEFENCE’S MELANOMA TARGETED VACCINE A1-REPROGRAMMED MSC (ARM) CELL POTENCY VALIDATED
Published on 04/16/2026 at 23:32, 38 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 2 hours 40 minutes ago Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 15:20, 8 hours 50 minutes ago Datavault AI Goes Live with First Edge GPU Sites in New York and Philadelphia; $1.44B-$1.92B Quantum-Ready Fleet to Reach 100+ U.S. Cities by End of 2026
Published on 04/16/2026 at 15:00, 9 hours 10 minutes ago FaZe Esports, a GameSquare Company, Announces Partnership with CORSAIR
Published on 04/16/2026 at 23:40, 30 minutes ago Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 2 hours 33 minutes ago Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 3 hours 10 minutes ago Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 3 hours 35 minutes ago EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 4 hours 52 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:02, 6 hours 8 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 6 hours 16 minutes ago Aéroports de Paris S.A - March 2026 traffic figures
